These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14617229)

  • 21. [Fasting or post-challenge blood glucose values for detection of glucose intolerance in screening for metabolic syndrome?].
    Jermendy G; Hidvégi T; Hetyési K; Bíró L
    Orv Hetil; 2002 Sep; 143(39):2247-52. PubMed ID: 12418378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulinemia--a marker of early diagnosis and control of efficacy of treatment of type II diabetes].
    Szybiński Z; Szurkowska M
    Pol Arch Med Wewn; 2001 Sep; 106(3):793-800. PubMed ID: 11928588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Area under the curve during OGTT in first-degree relatives of diabetic patients as an efficient indicator of future risk of type 2 diabetes and prediabetes.
    Feizi A; Meamar R; Eslamian M; Amini M; Nasri M; Iraj B
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):696-705. PubMed ID: 28793372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association.
    Mannucci E; Bardini G; Ognibene A; Rotella CM
    Diabet Med; 1999 Jul; 16(7):579-85. PubMed ID: 10445834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Type II diabetes mellitus and selected metabolic disorders in urban population aged over 35 years].
    Drzewoski J; Saryusz-Wolska M; Czupryniak L
    Pol Arch Med Wewn; 2001 Sep; 106(3):787-91. PubMed ID: 11928587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
    Hadaegh F; Zabetian A; Harati H; Azizi F
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of diabetes mellitus and intermediate glucose abnormalities in obese patients based on ADA (1997) and WHO (1985) criteria.
    Richard JL; Sultan A; Daures JP; Vannereau D; Parer-Richard C
    Diabet Med; 2002 Apr; 19(4):292-9. PubMed ID: 11943000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of factors associated with changes in the oral glucose tolerance test, regardless of the values of fasting glucose].
    Lauria MW; Dias IN; Soares MM; Cordeiro GV; Barbosa VE; Ramos AV
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):708-13. PubMed ID: 22231974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity Increases Prevalence of Colonic Adenomas at Screening Colonoscopy: A Canadian Community-Based Study.
    Shapero TF; Chen GI; Devlin T; Gibbs A; Murray IC; Tran S; Weigensberg C
    Can J Gastroenterol Hepatol; 2017; 2017():8750967. PubMed ID: 28781966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary patterns in a high-risk population for glucose intolerance. Japanese-Brazilian Diabetes Study Group.
    Costa MB; Ferreira SR; Franco LJ; Gimeno SG; Iunes M
    J Epidemiol; 2000 Mar; 10(2):111-7. PubMed ID: 10778035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subscapular skinfold thickness distinguishes between transient and persistent impaired glucose tolerance: Study on Lifestyle-Intervention and Impaired Glucose Tolerance Maastricht (SLIM).
    Mensink M; Feskens EJ; Kruijshoop M; de Bruin TW; Saris WH; Blaak EE
    Diabet Med; 2003 Jul; 20(7):552-7. PubMed ID: 12823236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.